1. H1N1 influenza vaccine: Global access for a global problem
- Author
-
Noni E. MacDonald
- Subjects
Canada ,business.industry ,International Cooperation ,H1N1 influenza ,Vaccination ,Global problem ,General Medicine ,medicine.disease_cause ,Global Health ,Virology ,Influenza A virus subtype H5N1 ,Health Services Accessibility ,Disease Outbreaks ,Influenza A Virus, H1N1 Subtype ,Editorial ,Influenza Vaccines ,Pandemic ,Influenza, Human ,medicine ,Human mortality from H5N1 ,Live attenuated influenza vaccine ,Humans ,business - Abstract
More than 90% of the world’s capacity to manufacture influenza vaccines is concentrated in Europe and North America. Pressure to protect one’s own citizens will be intense during any pandemic. If any of the countries where these plants are located choose to nationalize the companies making the
- Published
- 2009